NCT01750879View on ClinicalTrials.gov

Tolerance Following Peanut Oral Immunotherapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

July 11, 2017

Study Completion Date

July 11, 2017

Conditions
Peanut Allergy
Interventions
DRUG

Peanut Flour

Peanut Flour

DRUG

Oat Flour

Oat Flour

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Massachusetts General Hospital

OTHER

NCT01750879 - Tolerance Following Peanut Oral Immunotherapy | Biotech Hunter | Biotech Hunter